What Recugel Treats: Main Uses and Benefits

Recugel is a viscous ophthalmic formulation designed to support the natural healing process of the ocular surface. It is primarily used to provide lasting hydration and protection to the cornea, particularly when the eye’s outermost layer has been compromised.

Primary Uses

Recugel is indicated for the management of various non-inflammatory corneal conditions. Its application is common in the following scenarios:

• Corneal Erosions and Abrasions: It assists in the recovery of the corneal epithelium following minor injuries, scratches, or foreign body removal.
• Post-Surgical Recovery: It is often used as a supportive measure after ophthalmic surgeries, such as refractive procedures (LASIK or PRK), to maintain a moist environment necessary for tissue regeneration.
• Chronic Surface Damage: It provides relief for patients suffering from trophic changes in the cornea or recurrent epithelial defects.

Benefits and Mechanism of Action

The effectiveness of Recugel is derived from its ability to act as a protective lubricant and a physiological aid for tissue repair. Its key benefits include:

• Enhanced Hydration: The formulation contains dexpanthenol, a derivative of vitamin B5, which has a high water-binding capacity. This helps maintain the moisture levels of the eye surface for an extended period.
• Physical Protection: Due to its high viscosity, the gel forms a stable protective film over the cornea. This barrier shields the sensitive nerve endings and the injured epithelium from the mechanical friction caused by blinking.
• Support for Regeneration: By maintaining a moist and protected environment, the gel facilitates the natural migration and proliferation of corneal cells, which is essential for the restoration of a smooth ocular surface.
• Symptomatic Relief: It helps alleviate the discomfort, burning sensation, and feeling of grittiness often associated with corneal damage and extreme dryness.

Regulatory documents establish precise eligibility and non-eligibility rules for the use of this ophthalmic gel, which is formulated with dexpanthenol and a preservative (e.g., cetrimide).

Populations That Must Not Use Recugel (Contraindicated)

• Hypersensitivity/Allergy: Use is contraindicated in any individual with a documented allergy or known hypersensitivity to dexpanthenol or any other inactive ingredients (excipients) found in the gel formulation.

Populations with Restrictions or Non-Eligibility

• Contact Lens Wearers: The product must not be used while wearing contact lenses. The preservative in the gel can be absorbed by soft lenses, potentially causing eye irritation and damaging the lenses. Lenses should be removed before application, and reinsertion should be delayed for at least 15 minutes.
• Pregnancy and Lactation: Use is not recommended during pregnancy or breastfeeding due to a lack of sufficient safety data from human studies. Individuals in these groups should consult a healthcare professional before use.
• Age: The product is generally intended for use in adults (typically 18 years of age), as clinical studies establishing its safety and efficacy are commonly limited to this population. Safety and effectiveness in children and adolescents are not established in the official labeling.

Interactions with other medicines and products

The interaction profile for Recugel, an ophthalmic gel containing Dexpanthenol 5%, is primarily characterized by a physical, non-systemic interaction with other topical eye treatments. Official regulatory documentation for this formulation confirms the absence of documented systemic drug-drug interactions, as minimal systemic absorption occurs from the topical ocular application.

Timing and Administration Restrictions

The only official restriction concerns the co-administration sequence with other ophthalmic preparations, such as eye drops or ointments. This is due to the gel's high viscosity, which is designed to form a long-lasting protective film on the eye's surface. Applying a viscous gel first could physically prevent the subsequent absorption of lower-visviscosity products.

Absence of Systemic Interactions

Regulatory sources confirm that there are no documented metabolic interactions involving enzyme systems (such as CYP450) or drug transporters. Furthermore, no formal contraindicated combinations are listed in the official labeling for this product based on interaction risk. No interactions with food, alcohol, or herbal products are cited in the available regulatory documents.

Recugel's pharmacodynamic mechanism is mediated by its primary active component, dexpanthenol, a provitamin of pantothenic acid (vitamin B5).

Upon topical administration, dexpanthenol is absorbed by the ocular surface epithelial cells and is enzymatically converted to pantothenic acid. Pantothenic acid serves as an essential precursor for the synthesis of Coenzyme A (CoA).

Intracellularly, the increase in CoA content supports various metabolic pathways, including the synthesis of membrane phospholipids and cholesterol required for cellular repair. This modulation facilitates the integrity and regeneration of the epithelial barrier. Furthermore, dexpanthenol's action is associated with the upregulation of cell-cycle-regulating proteins, promoting the proliferation, migration, and attachment of fibroblasts and epithelial cells. This enhanced cellular kinetics and material synthesis accelerate the reparative process across the ocular surface. Dexpanthenol also displays hygroscopic properties, promoting hydration and increasing the molecular fluidity of the extracellular lamellae lipids and protein residues in the stratum corneum, which stabilizes the protective layer on the corneal and conjunctival epithelia.

Recugel is an ophthalmic gel containing dexpanthenol (Provitamin B5), which is used to improve the hydration of the ocular surface and support the regeneration of the corneal epithelium, often in cases of dry, tired, or burned eyes. It is intended for topical application into the eye.

Administration Instructions

1. Hand Preparation: Always wash your hands thoroughly before handling the tube or applying the gel to prevent microbial contamination.
2. Dosage: The typical regimen involves instilling one drop of the gel into the conjunctival sac of the affected eye(s). The conjunctival sac is the space between the eyeball and the lower eyelid.
3. Application: Hold the tube vertically above the eye. Gently pull your lower eyelid downward to create a small pocket. Squeeze the tube slightly to release a single drop of the gel into the pocket. Be careful not to let the tip of the tube touch your eye or any other surface to avoid contamination.
4. Distribution: After instillation, close your eye and move your eyeball slowly side-to-side to help the viscous gel spread optimally across the corneal surface.

Important Considerations

• Frequency: Recugel is typically applied three to five times a day or as directed by a healthcare professional.
• Contact Lenses: Contact lenses must be removed before using the gel, as the preservative (cetrimide) can be absorbed by the lens material. Lenses should not be reinserted for at least 15 minutes after application.
• Other Eye Products: If you are using other eye drops or ointments, allow approximately 15 minutes between applications to ensure each product can work effectively.
• Storage and Disposal: Store the gel between 1 C and 25 C (approximately 34 F and 77 F). Due to the risk of contamination, the tube should be discarded six weeks after first opening.

Research Evidence / Overview of Studies for Recugel

Evidence for Use in Corneal Epithelial Damage and Repair

Research exploring the use of Recugel, which contains dexpanthenol 5%, has been conducted primarily in populations with corneal epithelial damage, such as traumatic abrasions or damage following surgical procedures. The studies mainly focus on short-term outcomes related to the recovery of the eye's surface.

Researchers have examined whether a regimen including dexpanthenol affects the healing rate of the corneal epithelium and have applied in studies examining patient-reported experiences such as discomfort. Some studies reported patterns showing that the group receiving the dexpanthenol regimen had lower measured pain scores (VAS) at designated intervals compared to a non-dexpanthenol regimen. However, statistically significant differences were not described between the groups in epithelial healing rates or durations. Separately, studies focusing on the active ingredient reported that research described that measurements of disturbances of corneal epithelial permeability shifted in those receiving the dexpanthenol-containing formulation compared to dexpanthenol-free eye drops. This evidence contributes to understanding symptom patterns but research does not determine whether an individual will respond similarly.

Comparing Recugel to Placebo or Other Gels

The evidence landscape includes comparative research that has evaluated Recugel against other treatments. Some investigations are non-inferiority trials, which are used in research exploring the comparable performance of Recugel against other eye gels that contain the same 5% dexpanthenol active ingredient.

Duration of Studies and Long-Term Follow-Up Data

The current research primarily focuses on episodes where symptoms become more noticeable and healing is expected to occur rapidly. The typical follow-up durations were limited, often extending for only one week or one month after a corneal injury or procedure. This means that long-term effects are not fully established by the existing studies.

What is Still Uncertain About Recugel’s Evidence

The current evidence describes certain gaps and limitations. Certainty remains low in some areas due to factors such as sample sizes were modest in some key studies. Comparative evidence is lacking for certain scenarios, particularly large-scale, randomized trials comparing the 5% gel directly against a truly inactive placebo for the acute healing of corneal abrasions. Evidence described variability regarding certain objective measures like the epithelial healing rate in some trauma studies.

Key Studies & References

1. Effect of dexpanthenol on patient comfort in treatment of traumatic corneal abrasions
2. Evaluation of Dry Eye Treatment with Sodium Hyaluronate- and Dexpanthenol-Containing Eye Drops on Ocular Surface Improvement after Cataract Surgery

How to Store and Dispose of Recugel

Recugel eye gel must be stored and handled according to regulatory instructions to maintain its quality and sterility.

Storage Conditions and Stability

• Temperature: Store the unopened product below 25 C and do not refrigerate.
• Protection: The gel must be protected from light and moisture and kept in its tightly closed original container.
• In-Use Stability: The product must be discarded 28 days (or one month) after first opening the tube.
• Child Safety: Keep the ophthalmic gel out of the sight and reach of children.

Disposal

Unused, expired, or opened product (past the discard date) must be disposed of according to local regulations for pharmaceutical waste, not in regular household trash or wastewater.